A

ASST Fatebenefratelli Sacco | Luigi Sacco University Hospital - Gastroenterology and Digestive Endoscopy Department

Research site

(Unclaimed)

Location

Via Giovanni Battista Grassi, 74, Milan, Milan, Italy

Site insights

Top conditions

Top treatments

Esketamine

ANX007

Filgotinib

Ritonavir

Bictegravir

Enoxaparin

Lenacapavir

Nirmatrelvir

PF-04965842

Aticaprant

Parent organization

This site is a part of ASST Fatebenefratelli Sacco

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 16 total trials

Status recently updated

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Geographic Atrophy (GA) (ARCHER II)

The primary purpose of the study is to determine if IVT injections of vonaprument every month reduce vision loss in participants with GA secondary to...

Enrolling

Active, not recruiting

Geographic Atrophy

Drug: Vonaprument

Other: Sham Administration

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1)

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Active, not recruiting

HIV-1-infection

Drug: Stable Baseline Regimen

Drug: Bictegravir

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis (JADE EXTEND)

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting

Dermatitis, Atopic

Drug: Abrocitinib 200 mg

Drug: Abrocitinib 100 mg